According to recent research, percutaneous sclerotherapy for the treatment of aneurysmal bone cysts provides a secure substitute for surgery. We share our first-hand knowledge of this approach. Ten patients who received polidocanol injections repeatedly were examined. Polidocanol was injected in doses of 2 mg per kilogram of body weight. Clinical and radiological evaluations were done up to healing. After a mean of 4.7(1-11) injections, all cysts had healed. 1 individual had a small amount of local inflammation. Our findings demonstrate the high efficacy of percutaneous sclerotherapy with polidocanol in the treatment of ABCs, as well as its low frequency of adverse effects. Our results support the information provided in earlier publications. Since surgery is associated with significant morbidity in ABCs of the pelvis and sacrum, we think the approach will be especially helpful in these cases.

Background: Elderly people who have hip fractures frequently need blood transfusions. The purpose of this study was to ascertain whether tranexamic acid (TXA) usage in hip fracture patients lowers intraoperative and postoperative blood loss. For a year, patients with hip fractures were the subjects of the study. Two groups of patients were formed, with one getting TXA and the other receiving a placebo (1:1). Both the amount of drainage during the 48-hour postoperative period and the amount of blood lost during the procedure were measured. Patients who received TXA experienced a 1.4 fold reduction in total blood loss (368.61 vs.529.24 mL of blood). Thus the use of TXA in patients with per trochanteric fractures significantly reduces intraoperative and postoperative blood loss.